Skip to content
All news
Analysis

Is Johnson & Johnson (JNJ) Stock Still a Value After 73% Rally?

After Johnson & Johnson (JNJ) stock surged 73.5% in one year, investors question whether the stock still holds value. This analysis explores what the current price might imply about the company.

June 30, 2026
2 min read
Source: Simply Wall St.
Share:

Key Numbers

last close
258.51
one year return
73.5%
ytd return
24.7%
seven day return
11.8%
thirty day return
14.7%
three year return
72.7%
five year return
76.1%

After Johnson & Johnson (JNJ) stock surged 73.5% over the past year and closed at $258.51, investors are questioning whether the stock still holds value. The stock also gained 11.8% over 7 days, 14.7% over 30 days, and 24.7% year-to-date. These strong returns naturally raise questions about what is already priced in.

Valuation Analysis

Valuation analysis suggests that the stock may be fairly valued at current levels, with a P/E ratio of around 16x, in line with the healthcare sector average. However, expected earnings growth in the coming years may not be sufficient to drive the stock significantly higher.

Recent Stock Performance

The stock has delivered strong returns across timeframes:

  • 7 days: +11.8%
  • 30 days: +14.7%
  • Year-to-date: +24.7%
  • 1 year: +73.5%
  • 3 years: +72.7%
  • 5 years: +76.1%

What This Means for Investors

Despite the strong performance, investors should consider factors like future growth and valuation before making any decisions. The stock may not be undervalued, but it is also not significantly overvalued. The focus remains on the company's fundamentals and its ability to deliver growth.

Frequently Asked Questions

The stock returned 73.5% over the past year.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.